Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: A case control study

Twin Research and Human Genetics

Volumn 14, Issue 5, 2011, Pages 417-421

  Jedlinski, Dominik J ^a,b   Gabrovska, Plamena N ^a   Weinstein, Stephen R ^c   Smith, Robert A ^a   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF BASEL   (Switzerland)

^c GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

Breast cancer; Cancer risk; Micro RNA; rs11614913; SNP

Indexed keywords

MICRORNA; MICRORNA 196A 2; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RNA GENE; RNA PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM;

AUSTRALIA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICRORNAS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 80053473776     PISSN: 18324274     EISSN: None     Source Type: Journal    
DOI: 10.1375/twin.14.5.417     Document Type: Article

References (19)

1. American Cancer Society. (2007). Global cancer facts & figures 2007. Atlanta, GA: American Cancer Society.
2. Campeau, P. M., Foulkes, W. D., & Tischkowitz, M. D. (2008). Hereditary breast cancer: New genetic developments, new therapeutic avenues. Human Genetics, 124, 31-42.
3. Catucci, I., Yang, R., Verderio, P., Pizzamiglio, S., Heesen, L., Hemminki, K., Sutter, C., Wappenschmidt, B., Dick, M., Arnold, N., Bugert, P., Niederacher, D., Meindl, A., Schmutzler, R. K., Bartram, C. C., Ficarazzi, F., Tizzoni, L., Zaffaroni, D., Manoukian, S., Barile, M., Pierotti, M. A., Radice, P., Burwinkel, B., & Peterlongo, P. (2009). Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Human Mutation, 31, E1052-1057.
4. Curran, J. E., Weinstein, S. R., & Griffiths, L. R. (2002). Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Letters, 188, 103-107. (Pubitemid 35292335)
5. Davalos, V., & Esteller, M. MicroRNAs and cancer epigenetics: A macrorevolution. Current Opinion in Oncology, 22, 35-45.
6. Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., Wareham, N., Ahmed, S., Healey, C. S., Bowman, R, SEARCH collaborators., Meyer, K. B., Haiman, C. A., Kolonel, L. K., Henderson, B. E., Le, Marchand, L., Brennan, P., Sangrajrang, S., Gaborieau, V., Odefrey, F., Shen, C. Y., Wu, P. E., Wang, H. C., Eccles, D., Evans, D. G., Peto, J., Fletcher, O., Johnson, N., Seal, S., Stratton, M. R., Rahman, N., Chenevix-Trench, G., Bojesen, S. E., Nordestgaard, B. G., Axelsson, C. K., Garcia-Closas, M., Brinton, L., Chanock, S., Lissowska, J., Peplonska, B., Nevanlinna, H., Fagerholm, R., Eerola, H., Kang, D., Yoo, K. Y., Noh, D. Y., Ahn, S. H., Hunter, D. J., Hankinson, S. E., Cox, D. G., Hall, P., Wedren, S., Liu, J., Low, Y. L., Bogdanova, N., Schürmann, P., Dörk, T., Tollenaar, R. A., Jacobi, CE., Devilee, P., Klijn, JG., Sigurdson, A. J., Doody, M. M., Alexander, B. H., Zhang, J., Cox, A., Brock, I. W., MacPherson, G., Reed, M. W., Couch, F. J., Goode, E. L., Olson, J. E., Meijers-Heijboer, H., van, den, Ouweland, A., Uitterlinden, A., Rivadeneira, F., Milne, R. L., Ribas, G., Gonzalez-Neira, A., Benitez, J., Hopper, J. L., McCredie, M., Southey, M., Giles, G. G., Schroen, C., Justenhoven, C., Brauch, H., Hamann, U., Ko, Y. D., Spurdle, A. B., Beesley, J., Chen, X, kConFab, AOCS Management, Group., Mannermaa, A., Kosma, V. M., Kataja, V., Hartikainen, J., Day, N. E., Cox, D. R., & Ponder, B. A. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-1093. (Pubitemid 47014426)
7. Esquela-Kerscher, A., & Slack, F. J. (2006). Oncomirs - microRNAs with a role in cancer. Nature Reviews Cancer, 6, 259-269.
8. Gao, L. B., Bai, P., Pan, X. M., Jia, J., Li, L. J., Liang, W. B., Tang, M., Zhang, L. S., Wei, Y. G., & Zhang, L. (2011). The association between two polymorphisms in pre-miRNAs and breast cancer risk: A meta-analysis. Breast Cancer Research and Treatment, 125, 571-574.
9. Hoffman, A. E., Zheng, T., Yi, C., Leaderer, D., Weidhaas, J., Slack, F., Zhang, Y., Paranjape, T., & Zhu, Y. (2009). microRNA miR-196a-2 and breast cancer: A genetic and epigenetic association study and functional analysis. Cancer Research, 69, 5970-5977.
10. Hu, Z., Liang, J., Wang, Z., Tian, T., Zhou, X., Chen, J., Miao, R., Wang, Y., Wang, X., & Shen, H. (2009). Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Human Mutation, 30, 79-84.
11. Iorio, M. V., Ferracin, M., Liu, C. G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., Ménard, S., Palazzo, J. P., Rosenberg, A., Musiani, P., Volinia, S., Nenci, I., Calin, G. A., Querzoli, P., Negrini, M., & Croce, C. M. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Research, 65, 7065-7070. (Pubitemid 41161233)
12. Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-773. (Pubitemid 40292988)
13. Loman, N., Johannsson, O., Kristoffersson, U., Olsson, H., & Borg, A. (2001). Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. Journal of the National Cancer Institute, 93, 1215-1223. (Pubitemid 32816196)
14. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., Downing, J. R., Jacks, T., Horvitz, H. R., & Golub, T. R. (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-838. (Pubitemid 40839735)
15. Tian, T., Shu, Y., Chen, J., Hu, Z., Xu, L., Jin, G., Liang, J., Liu, P., Zhou, X., Miao, R., Ma, H., Chen, Y., & Shen, H. (2009). A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiology, Biomarkers and Prevention, 18, 1183-1187.
16. Verghese, E., Hanby, A., Speirs, V., & Hughes, T. (2008). Small is beautiful: MicroRNAs and breast cancer-where are we now? Journal of Pathology, 215, 214-221. (Pubitemid 351956702)
17. Wightman, B., Ha, I., & Ruvkun, G. (1993). Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell, 75, 855-862. (Pubitemid 24014543)
18. Yekta, S., Shih, I. H., & Bartel, D. P. (2004). MicroRNA-directed cleavage of HOXB8 mRNA. Science, 304, 594-596. (Pubitemid 38541919)
19. Zhang, B. H., Pan, X. P., Cobb, G. P., & Anderson, T. A. (2007). MicroRNAs as oncogenes and tumor suppressors. Developmental Biology, 302, 1-12. (Pubitemid 46096921)